{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:57:35Z","timestamp":1790740655640,"version":"4.1.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI132606"],"award-info":[{"award-number":["R01 AI132606"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI153521"],"award-info":[{"award-number":["R01 AI153521"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The emergence of multidrug-resistant Neisseria gonorrhoeae has created an urgent need for new therapeutic options. Zoliflodacin and gepotidacin, 2 first-in-class topoisomerase inhibitors, are oral antibiotics recently approved by the FDA for gonorrhea treatment. Resistance to zoliflodacin can occur through gyrBD429N, but this mutation's impact on fitness and on resistance to other topoisomerase-targeting drugs have been unclear. The aim of this study was to investigate the in vitro fitness and antibiotic resistance implications of gyrBD429N in ciprofloxacin-resistant N. gonorrhoeae strains.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We introduced the gyrBD429N substitution into 9 clinical strains via transformation. Antimicrobial susceptibility testing was performed for zoliflodacin, gepotidacin, and ciprofloxacin using standard MIC assays. In vitro relative fitness of parent and resistant mutant strains was assessed by pairwise competition experiments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>gyrB D429N conferred cross-resistance to gepotidacin in 3 clinical strains, and its fitness effect varied by strain background. In particular, parCD86N appeared to potentiate gyrBD429N cross-resistance to gepotidacin, a drug for which resistance has previously only been seen in the presence of both parCD86N and gyrAA92T mutations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Genetic background modulated the phenotypic effects of a zoliflodacin-resistance determinant on fitness and cross-resistance to gepotidacin. These findings inform strategies for introducing the new topoisomerase inhibitors into clinical use and for surveillance of resistance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/infdis\/jiag174","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:53:55Z","timestamp":1773838435000},"page":"e131-e140","source":"Crossref","is-referenced-by-count":6,"title":["Genetic Background Modulates Zoliflodacin and Gepotidacin Cross-Resistance and Fitness in\n                    <i>Neisseria gonorrhoeae<\/i>"],"prefix":"10.1093","volume":"234","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2208-9945","authenticated-orcid":false,"given":"Aditi","family":"Mukherjee","sequence":"first","affiliation":[{"name":"Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8967-3564","authenticated-orcid":false,"given":"Sofia O P","family":"Blomqvist","sequence":"additional","affiliation":[{"name":"Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9319-7097","authenticated-orcid":false,"given":"David","family":"Helekal","sequence":"additional","affiliation":[{"name":"Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apabrita A","family":"Das","sequence":"additional","affiliation":[{"name":"Cardiovascular Medicine Division, Brigham and Women's Hospital , Boston, Massachusetts ,","place":["USA"]},{"name":"Harvard Medical School , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7849-8078","authenticated-orcid":false,"given":"Samantha G","family":"Palace","sequence":"additional","affiliation":[{"name":"Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5646-1314","authenticated-orcid":false,"given":"Yonatan H","family":"Grad","sequence":"additional","affiliation":[{"name":"Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"2026080313230795200_jiag174-B1","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/jac\/dkaf109","article-title":"The continuing evolution of antibiotic resistance in Neisseria gonorrhoeae: past, present and future threats to effective treatment","volume":"80","author":"Fifer","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"2026080313230795200_jiag174-B2","doi-asserted-by":"crossref","first-page":"e00048-19","DOI":"10.1128\/CMR.00048-19","article-title":"Antimicrobial resistance surveillance in low- and middle-income countries: progress and challenges in eight south Asian and southeast Asian countries","volume":"33","author":"Gandra","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"2026080313230795200_jiag174-B3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.15585\/mmwr.mm7312a2","article-title":"Ceftriaxone-resistant gonorrhea\u2014China, 2022","volume":"73","author":"Zhu","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026080313230795200_jiag174-B4","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1093\/infdis\/jiaf071","article-title":"High prevalence of ceftriaxone-resistant Neisseria gonorrhoeae in Hanoi, Vietnam, 2023\u20132024","volume":"232","author":"Laumen","year":"2025","journal-title":"J Infect Dis"},{"key":"2026080313230795200_jiag174-B5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0140-6736(25)01953-1","article-title":"Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial","volume":"407","author":"Luckey","year":"2026","journal-title":"Lancet"},{"key":"2026080313230795200_jiag174-B6","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/S0140-6736(25)00628-2","article-title":"Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea (EAGLE-1): a phase 3 randomised, open-label, non-inferiority, multicentre study","volume":"405","author":"Ross","year":"2025","journal-title":"Lancet"},{"key":"2026080313230795200_jiag174-B7","author":"U.S. Food and Drug Administration","year":"2025"},{"key":"2026080313230795200_jiag174-B8","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1021\/acsinfecdis.5c00497","article-title":"Mechanism of action of gepotidacin: well-balanced dual-targeting against Neisseria gonorrhoeae gyrase and topoisomerase IV in cells and in vitro","volume":"11","author":"Oviatt","year":"2025","journal-title":"ACS Infect Dis"},{"key":"2026080313230795200_jiag174-B9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2958.1994.tb01297.x","article-title":"Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates","volume":"14","author":"Belland","year":"1994","journal-title":"Mol Microbiol"},{"key":"2026080313230795200_jiag174-B10","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1128\/AAC.04456-14","article-title":"Characterization of the novel DNA gyrase inhibitor AZD0914: low resistance potential and lack of cross-resistance in Neisseria gonorrhoeae","volume":"59","author":"Alm","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2026080313230795200_jiag174-B11","doi-asserted-by":"crossref","first-page":"e247","DOI":"10.1016\/S2666-5247(22)00356-1","article-title":"Neisseria gonorrhoeae diagnostic escape from a gyrA-based test for ciprofloxacin susceptibility and the effect on zoliflodacin resistance: a bacterial genetics and experimental evolution study","volume":"4","author":"Rubin","year":"2023","journal-title":"Lancet Microbe"},{"key":"2026080313230795200_jiag174-B12","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1093\/jac\/dkz376","article-title":"In vitro antimicrobial combination testing of and evolution of resistance to the first-in-class spiropyrimidinetrione zoliflodacin combined with six therapeutically relevant antimicrobials for Neisseria gonorrhoeae","volume":"74","author":"Foerster","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2026080313230795200_jiag174-B13","doi-asserted-by":"crossref","first-page":"874176","DOI":"10.3389\/fphar.2022.874176","article-title":"Pharmacodynamic evaluation of zoliflodacin treatment of Neisseria gonorrhoeae strains with amino acid substitutions in the zoliflodacin target GyrB using a dynamic hollow fiber infection model","volume":"13","author":"Jacobsson","year":"2022","journal-title":"Front Pharmacol"},{"key":"2026080313230795200_jiag174-B14","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/cid\/ciy145","article-title":"Gepotidacin for the treatment of uncomplicated urogenital gonorrhea: a phase 2, randomized, dose-ranging, single-oral dose evaluation","volume":"67","author":"Taylor","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2026080313230795200_jiag174-B15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/sextrans-2022-055518","article-title":"Dose selection for a phase III study evaluating gepotidacin (GSK2140944) in the treatment of uncomplicated urogenital gonorrhoea","volume":"99","author":"Scangarella-Oman","year":"2023","journal-title":"Sex Transm Infect"},{"key":"2026080313230795200_jiag174-B16","doi-asserted-by":"crossref","first-page":"e01221-18","DOI":"10.1128\/AAC.01221-18","article-title":"Microbiological analysis from a phase 2 randomized study in adults evaluating single oral doses of gepotidacin in the treatment of uncomplicated urogenital gonorrhea caused by Neisseria gonorrhoeae","volume":"62","author":"Scangarella-Oman","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2026080313230795200_jiag174-B17","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1093\/jac\/dky162","article-title":"In vitro activity of the novel triazaacenaphthylene gepotidacin (GSK2140944) against MDR Neisseria gonorrhoeae","volume":"73","author":"Jacobsson","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2026080313230795200_jiag174-B18","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1021\/acsinfecdis.0c00021","article-title":"Zoliflodacin: an oral spiropyrimidinetrione antibiotic for the treatment of Neisseria gonorrheae, including multi-drug-resistant isolates","volume":"6","author":"Bradford","year":"2020","journal-title":"ACS Infect Dis"},{"key":"2026080313230795200_jiag174-B19","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1128\/AAC.35.4.622","article-title":"Characterization of a gyrB mutation responsible for low-level nalidixic acid resistance in Neisseria gonorrhoeae","volume":"35","author":"Stein","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"2026080313230795200_jiag174-B20","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/infdis\/jiad027","article-title":"Whole-genome sequencing to predict antimicrobial susceptibility profiles in Neisseria gonorrhoeae","volume":"227","author":"Bristow","year":"2023","journal-title":"J Infect Dis"},{"key":"2026080313230795200_jiag174-B21","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/jac\/dkaa040","article-title":"Genomic analysis and antimicrobial resistance of Neisseria gonorrhoeae isolates from Vietnam in 2011 and 2015\u201316","volume":"75","author":"Lan","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"2026080313230795200_jiag174-B22","doi-asserted-by":"crossref","first-page":"e478","DOI":"10.1016\/S2666-5247(23)00370-1","article-title":"Antimicrobial-resistant Neisseria gonorrhoeae in Europe in 2020 compared with in 2013 and 2018: a retrospective genomic surveillance study","volume":"5","author":"Golparian","year":"2024","journal-title":"Lancet Microbe"},{"key":"2026080313230795200_jiag174-B23","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/jac\/dkac158","article-title":"Genomic surveillance and antimicrobial resistance in Neisseria gonorrhoeae isolates in Bangkok, Thailand in 2018","volume":"77","author":"Golparian","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"2026080313230795200_jiag174-B24","author":"Li"},{"key":"2026080313230795200_jiag174-B25","doi-asserted-by":"crossref","first-page":"e112963","DOI":"10.1371\/journal.pone.0112963","article-title":"Pilon: an integrated tool for comprehensive microbial variant detection and genome assembly improvement","volume":"9","author":"Walker","year":"2014","journal-title":"PLoS One"},{"key":"2026080313230795200_jiag174-B26","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence alignment\/map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"2026080313230795200_jiag174-B27","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1093\/nar\/gku1196","article-title":"Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins","volume":"43","author":"Croucher","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2026080313230795200_jiag174-B28","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/molbev\/msaa015","article-title":"IQ-TREE 2: new models and efficient methods for phylogenetic inference in the genomic era","volume":"37","author":"Minh","year":"2020","journal-title":"Mol Biol Evol"},{"key":"2026080313230795200_jiag174-B29","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nmeth.4285","article-title":"ModelFinder: fast model selection for accurate phylogenetic estimates","volume":"14","author":"Kalyaanamoorthy","year":"2017","journal-title":"Nat Methods"},{"issue":"W1","key":"2026080313230795200_jiag174-B30","doi-asserted-by":"crossref","first-page":"W78","DOI":"10.1093\/nar\/gkae268","article-title":"Interactive tree of life (iTOL) v6: recent updates to the phylogenetic tree display and annotation tool","volume":"52","author":"Letunic","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"2026080313230795200_jiag174-B31","first-page":"101125","article-title":"The WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) identifies high levels of ceftriaxone resistance across Vietnam, 2023","volume":"48","author":"Lan","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"key":"2026080313230795200_jiag174-B32","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.3201\/eid3007.240354","article-title":"World health organization enhanced gonococcal antimicrobial surveillance programme, Cambodia, 2023","volume":"30","author":"Ouk","year":"2024","journal-title":"Emerg Infect Dis"},{"key":"2026080313230795200_jiag174-B33","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41592-022-01488-1","article-title":"ColabFold: making protein folding accessible to all","volume":"19","author":"Mirdita","year":"2022","journal-title":"Nat Methods"},{"key":"2026080313230795200_jiag174-B34","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nprot.2016.169","article-title":"The ClusPro web server for protein-protein docking","volume":"12","author":"Kozakov","year":"2017","journal-title":"Nat Protoc"},{"key":"2026080313230795200_jiag174-B35","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"UCSF ChimeraX: structure visualization for researchers, educators, and developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci"},{"key":"2026080313230795200_jiag174-B36","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41564-025-02235-w","article-title":"Quantifying the real-world impact of antibiotic use and genetic determinants of resistance on gonococcal dynamics","volume":"11","author":"Helekal","year":"2026","journal-title":"Nat Microbiol"},{"key":"2026080313230795200_jiag174-B37","doi-asserted-by":"crossref","first-page":"btaf474","DOI":"10.1093\/bioinformatics\/btaf474","article-title":"Autocycler: long-read consensus assembly for bacterial genomes","volume":"41","author":"Wick","year":"2025","journal-title":"Bioinformatics"},{"key":"2026080313230795200_jiag174-B38","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1101\/gr.215087.116","article-title":"Canu: scalable and accurate long-read assembly via adaptive k-mer weighting and repeat separation","volume":"27","author":"Koren","year":"2017","journal-title":"Genome Res"},{"key":"2026080313230795200_jiag174-B39","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41587-019-0072-8","article-title":"Assembly of long, error-prone reads using repeat graphs","volume":"37","author":"Kolmogorov","year":"2019","journal-title":"Nat Biotechnol"},{"key":"2026080313230795200_jiag174-B40","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1093\/bioinformatics\/btw152","article-title":"Minimap and miniasm: fast mapping and de novo assembly for noisy long sequences","volume":"32","author":"Li","year":"2016","journal-title":"Bioinformatics"},{"key":"2026080313230795200_jiag174-B41","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41467-020-20236-7","article-title":"Efficient assembly of nanopore reads via highly accurate and intact error correction","volume":"12","author":"Chen","year":"2021","journal-title":"Nat Commun"},{"key":"2026080313230795200_jiag174-B42","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13059-024-03252-4","article-title":"NextDenovo: an efficient error correction and accurate assembly tool for noisy long reads","volume":"25","author":"Hu","year":"2024","journal-title":"Genome Biol"},{"key":"2026080313230795200_jiag174-B43","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s43588-021-00073-4","article-title":"Time- and memory-efficient genome assembly with raven","volume":"1","author":"Vaser","year":"2021","journal-title":"Nat Comput Sci"},{"key":"2026080313230795200_jiag174-B44","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1093\/bioinformatics\/bty191","article-title":"Minimap2: pairwise alignment for nucleotide sequences","volume":"34","author":"Li","year":"2018","journal-title":"Bioinformatics"},{"key":"2026080313230795200_jiag174-B45","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1093\/bioinformatics\/btu153","article-title":"Prokka: rapid prokaryotic genome annotation","volume":"30","author":"Seemann","year":"2014","journal-title":"Bioinformatics"},{"key":"2026080313230795200_jiag174-B46","author":"BLUJEPA (Gepotidacin)"},{"key":"2026080313230795200_jiag174-B47","doi-asserted-by":"crossref","first-page":"e781","DOI":"10.1016\/S2666-5247(23)00145-3","article-title":"Resistance-minimising strategies for introducing a novel antibiotic for gonorrhoea treatment: a mathematical modelling study","volume":"4","author":"Reichert","year":"2023","journal-title":"Lancet Microbe"},{"key":"2026080313230795200_jiag174-B48","doi-asserted-by":"crossref","first-page":"S249","DOI":"10.1093\/cid\/ciaf524","article-title":"Comparing strategies to introduce two new antibiotics for gonorrhea: a modeling study","volume":"81","author":"Kline","year":"2026","journal-title":"Clin Infect Dis"},{"key":"2026080313230795200_jiag174-B49","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41564-022-01282-x","article-title":"CanB is a metabolic mediator of antibiotic resistance in Neisseria gonorrhoeae","volume":"8","author":"Rubin","year":"2023","journal-title":"Nat Microbiol"},{"key":"2026080313230795200_jiag174-B50","doi-asserted-by":"crossref","first-page":"1900210","DOI":"10.2807\/1560-7917.ES.2020.25.43.1900210","article-title":"Using rapid point-of-care tests to inform antibiotic choice to mitigate drug resistance in gonorrhoea","volume":"25","author":"Vegvari","year":"2020","journal-title":"Euro Surveill"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiag174\/67422300\/jiag174.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/234\/1\/e131\/67422300\/jiag174.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/234\/1\/e131\/67422300\/jiag174.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T17:23:19Z","timestamp":1785777799000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/234\/1\/e131\/8529586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3,19]]},"published-print":{"date-parts":[[2026,8,3]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiag174","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7,15]]},"published":{"date-parts":[[2026,3,19]]}}}